Amanda L. Robichaud
-
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 2
- Cancer therapeutics and mechanisms 1
-
- Acute Myeloid Leukemia Research 1
-
- Advanced Breast Cancer Therapies 2
- Sarcoma Diagnosis and Treatment 1
-
- Neuroblastoma Research and Treatments 2
-
- Mast cells and histamine 1
- Co-authors
- Kimberly StegmaierAmy Saur ConwayJoseph D. ManciasMiljan KuljaninBo Kyung A. SeongJames E. BradnerBehnam NabetFleur M. Ferguson
- Cited by
- Molecular BiologyOncologyHematology
- Journals
- Cancer Research (2 papers)Cancer Discovery (2 papers)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Amanda L. Robichaud
9 papers receiving 367 citations
Peers
Comparison fields: 5 of 44
- Molecular Biology 280
- Oncology 105
- Hematology 36
- Cancer Research 47
- Pathology and Forensic Medicine 29
Countries citing papers authored by Amanda L. Robichaud
This map shows the geographic impact of Amanda L. Robichaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda L. Robichaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda L. Robichaud more than expected).
Fields of papers citing papers by Amanda L. Robichaud
This network shows the impact of papers produced by Amanda L. Robichaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda L. Robichaud. The network helps show where Amanda L. Robichaud may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amanda L. Robichaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2021 | 23 | |
| 3 | 2021 | 36 | |
| 4 | 2020 | 163 | |
| 5 | 2020 | 5 | |
| 6 | 2019 | 26 | |
| 7 | 2018 | 46 | |
| 8 | 2018 | 62 | |
| 9 | 2018 | 1 |
About Amanda L. Robichaud
Amanda L. Robichaud is a scholar working on Oncology, Neurology, Reproductive Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 370 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Advanced Breast Cancer Therapies (2 papers), Ubiquitin and proteasome pathways (2 papers), Neuroblastoma Research and Treatments (2 papers), Cancer therapeutics and mechanisms (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Mast cells and histamine (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Molecular Biology (280 citations), Oncology (105 citations), Hematology (36 citations), Cancer Research (47 citations) and Pathology and Forensic Medicine (29 citations). Amanda L. Robichaud has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Kimberly Stegmaier, Amy Saur Conway, Joseph D. Mancias, Miljan Kuljanin, Bo Kyung A. Seong, James E. Bradner, Behnam Nabet, Fleur M. Ferguson, Dennis L. Buckley and Alan L. Leggett. Their work appears in journals such as Cancer Research, Cancer Discovery, The Journal of Experimental Medicine, Clinical Cancer Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.